We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Ultra-Portable Rapid Test Platform Offers Complete Sample-to-Answer Solution for Remote and Off-Grid Testing

By LabMedica International staff writers
Posted on 07 Jun 2023
Print article
Image: The Geo portable testing platform integrated with the Snap collection device (Photo courtesy of ReadyGo Diagnostics)
Image: The Geo portable testing platform integrated with the Snap collection device (Photo courtesy of ReadyGo Diagnostics)

An ultra-portable isothermal molecular diagnostics system integrated with a patented device which combines sample collection and processing into a single, easy-to-use disposable is set to revolutionize low-cost decentralized diagnostic testing.

ReadyGo Diagnostics’ (Bath, UK) Geo is a rapid test platform designed for small labs, pharmacies, and remote diagnostic needs. This highly portable device enables molecular tests to be run anywhere and delivers results in approximately 20 minutes. Designed to go anywhere, Geo uses ReadyGo’s Flex reagents which do not require cold-chain, making it a true off-grid, go-anywhere test platform. The platform also does not require a specialized operator or accurate pipetting thanks to its pre-measured reagents.

Combined with ReadyGo's innovative sample collection device, Snap, Geo offers a comprehensive solution for remote and off-grid testing of up to eight samples simultaneously. Snap, a compact, single-use device about the size of a highlighter pen, integrates sample collection and preparation. It uses a specialized material to absorb a specified amount of the patient's sample via capillary action, which is then mixed with a dried lysis reagent stored within the device. The reagent's components are similar to those in mouthwash, safe for human use, and highly effective at breaking down pathogens without inhibiting nucleic acid amplification reactions.

Operating the Snap device is simple: the user collects a sample, and bends the device to break an internal valve, releasing the exact amount of buffer required for the reaction into the chamber. Then, the user simply squeezes the bulb on the end of the device to release the contents for diagnostic testing. This simple sample preparation method also reduces the cost of the diagnostic assay, as it does not require any moving components. Snap eliminates the buffer measuring step, which some users found challenging when using over-the-counter lateral flow COVID-19 tests. When paired with Geo's eight-well isothermal amplification platform, the user can directly transfer Snap's contents into tubes pre-filled with assay reagents, then place the tubes in the Geo instrument for amplification and reading. Snap can be used with various samples, including saliva, nasal, buccal, and even surface samples, with ReadyGo also developing options for blood, urine, and stool sample collection.

ReadyGo has designed tests using recombinase polymerase amplification (RPA) and loop-mediated isothermal amplification (LAMP) for Geo's isothermal amplification and is currently developing its proprietary chemistry. The Geo platform is expected to be priced under USD 1,000, with individual assays costing around USD 10, making it a low-cost diagnostic solution for small labs and research groups. Additionally, the Geo system is designed for 3D printing in its manufacturing process, in line with ReadyGo’s goal to decentralize production and commercialization. This design will allow the system to be produced locally wherever testing is required and also provide the benefit of lower assembly costs in various parts of the world. The Geo system's streamlined design also reduces the need for plastics in its construction. ReadyGo aims to collaborate with other labs and companies, as well as develop tests that can be commercialized by its partners.

Related Links:
ReadyGo Diagnostics 

Gold Member
Troponin T QC
Troponin T Quality Control
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
New
Anti-Annexin V IgG/IgM Assay
Anti-Annexin V IgG/IgM ELISA
New
Parasite Suspension for QC
Cryptosporidium Species Parasite Suspension

Print article

Channels

Immunology

view channel
Image: Example image of the high-throughput microscopy method used in the study, showing immune cells stained with different fluorescence markers (Photo courtesy of Felix Kartnig/CeMM, MedUni Vienna)

Cutting-Edge Microscopy Technology Enables Tailored Rheumatology Therapies

Rheumatoid arthritis is the most common inflammatory joint disorder, with women three times as likely to suffer from the condition as men. Treatment advances made over the past decades have led to the... Read more

Microbiology

view channel
Image: RNA sequencing directly from whole blood aims to expand access to LRTI testing (Photo courtesy of CARB-X)

Novel Test to Diagnose Bacterial Pneumonia Directly from Whole Blood

Pneumonia and lower-respiratory-tract infections (LRTIs) are among the top causes of illness and death globally, particularly in vulnerable populations such as the elderly, young children, and immunocompromised... Read more

Pathology

view channel
Image: Lunit SCOPE HER2 is an AI-powered solution designed to detect HER2 expression profile (Photo courtesy of Lunit)

AI-Powered Pathology Solutions Accurately Predict Outcomes for HER2-Targeted Therapy in Metastatic CRC

A new study has highlighted how artificial intelligence (AI)-powered analysis of HER2 and the tumor microenvironment (TME) can improve patient stratification and predict clinical outcomes more effectively.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.